Department of Obstetrics and Gynecology, West China Second University Hospital of Sichuan University, Chengdu, Sichuan, People's Republic of China.
Key Laboratory of Birth Defects and Related Diseases of Women and Children, Sichuan University, Ministry of Education, West China Second University Hospital of Sichuan University, Chengdu, Sichuan, People's Republic of China.
Endocrinology. 2018 Jul 1;159(7):2554-2562. doi: 10.1210/en.2018-00374.
Progesterone resistance in the eutopic endometrium (EuE) is suggested to be a critical factor for decreased endometrial receptivity and implantation failure in reproductive-aged women with endometriosis. Altered expression of miRNAs has been reported to play an important role in the pathophysiology of endometriosis-associated infertility. However, the underlying mechanisms of aberrant progesterone receptor (PR) and deficient decidualization regulated by miRNAs in endometriosis have not been thoroughly elucidated. The goal of this study was to explore the regulation and roles of miR-194-3p in aberrant PR expression and impaired decidualization in endometrial stromal cells (ESCs) from the EuE of women with mild or minimal endometriosis. Using a series of studies, we observed decreased PR mRNA expression and an increasing PR-A/PR-B mRNA ratio trend in the midsecretory phase of the EuE of women with minimal or mild endometriosis (n = 19) compared with controls (n = 14); the increased expression of miR-194-3p in the endometriosis group was consistent with previous microarray analysis. We also found that PR protein levels were inhibited by the transfection of ESCs with an miR-194-3p mimic and upregulated by miR-194-3p inhibition. As predicted by the bioinformatic analysis, the 3'-untranslated region luciferase assay indicated the direct regulation of PR expression by miR-194-3p. Furthermore, miR-194-3p overexpression inhibited the in vitro decidualization of ESCs via both cellular morphological changes and prolactin levels. Therefore, our study demonstrated that miR-194-3p contributes to progesterone resistance in endometriosis, which hinders fertility by repressing the levels of PR and decidualization in the EuE. Thus, miR-194-3p regulation is a future therapeutic strategy for endometriosis.
在位子宫内膜(EuE)中的孕激素抵抗被认为是导致生育期子宫内膜异位症妇女子宫内膜容受性降低和着床失败的关键因素。已有研究报道,miRNA 的表达改变在子宫内膜异位症相关不孕的病理生理学中发挥重要作用。然而,miRNA 调控异常孕激素受体(PR)和蜕膜化缺陷的潜在机制在子宫内膜异位症中尚未得到充分阐明。本研究旨在探讨 miR-194-3p 在轻度或微小子宫内膜异位症妇女 EuE 中的子宫内膜基质细胞(ESCs)中异常 PR 表达和蜕膜化受损中的调节作用和作用。通过一系列研究,我们观察到微小或轻度子宫内膜异位症患者(n=19)EuE 的中分泌期 PR mRNA 表达降低且 PR-A/PR-B mRNA 比值呈上升趋势,与对照组(n=14)相比;miR-194-3p 在子宫内膜异位症组中的表达增加与之前的微阵列分析一致。我们还发现,转染 miR-194-3p 模拟物可抑制 PR 蛋白水平,而 miR-194-3p 抑制则上调 PR 蛋白水平。生物信息学分析预测,3'UTR 荧光素酶测定表明 PR 表达受 miR-194-3p 的直接调控。此外,miR-194-3p 过表达通过细胞形态变化和催乳素水平抑制 ESCs 的体外蜕膜化。因此,我们的研究表明,miR-194-3p 导致子宫内膜异位症中的孕激素抵抗,通过抑制 EuE 中 PR 和蜕膜化的水平来阻碍生育能力。因此,miR-194-3p 的调节可能是子宫内膜异位症的一种未来治疗策略。